Related Experiment Video
Updated: Nov 3, 2025
08:04
Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol
Published on: November 3, 2023
2.2K
Insulin release bio-platform from all nano-container assembled thin films
1Department of Plant & Environmental New Resources, College of Life Science, Kyung Hee University, Yongin-si 446-701, Republic of Korea.
Summary
This study presents novel nano-container multilayer structures for controlled human insulin release. These structures utilize block copolymer micelles, showing promise for advanced drug delivery systems and biomedical applications.
Area of Science:
- Materials Science
- Biomedical Engineering
- Nanotechnology
Background:
- Controlled drug delivery systems are crucial for therapeutic efficacy.
- Block copolymer micelles (BCMs) offer potential as nano-containers for drug encapsulation.
- Layer-by-layer (LbL) assembly provides a versatile method for creating multilayer thin films.
Purpose of the Study:
- To develop and characterize nano-container assembled multilayer structures for controlled human insulin release.
- To investigate the dissociation behavior of BCMs within LbL structures under physiological conditions.
- To evaluate the biocompatibility of BCM multilayer thin films for potential biomedical applications.
Main Methods:
- Synthesis of polystyrene-block-poly(4-vinylpyridine) and polystyrene-block-poly(acrylic acid) micelles.
- Layer-by-layer (LbL) assembly of BCMs to form multilayer thin films.
- Encapsulation of human insulin within the BCM multilayer structures.
- In vitro evaluation of BCM multilayer structure deconstruction and insulin release under simulated physiological conditions (37°C, 5% CO2, PBS pH 7.4).
- Assessment of cell viability and adhesion (MC3T3 cells) on BCM multilayer thin films.
Main Results:
- Successfully assembled BCM multilayer structures capable of encapsulating human insulin.
- Demonstrated deconstruction of BCM multilayer structures upon rehydration in model physiological conditions.
- Observed release of BCMs as insulin carriers, with dissociation behavior influenced by BCM combinations.
- Confirmed cell viability and adhesion on the developed BCM multilayer thin films, indicating good biocompatibility.
Conclusions:
- Nano-container assembled multilayer structures using BCMs are effective for controlled human insulin release.
- The dissociation characteristics of BCMs within LbL structures can be tuned by BCM selection, impacting drug release profiles.
- These functional platforms hold significant potential for developing advanced biomedical applications, particularly in targeted and controlled drug delivery.
Related Concept Videos
01:05Insulin Secretory Vesicles
6.1K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.1K
01:25Insulin: Biosynthesis, Chemistry, and Preparation
730
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
730